The pharmaceutical industry must direct additional focus on the development of agents to prevent or minimize symptoms of cancer and its treatment, and maximize the quality of life of cancer patients. This paper covers the current status of cancer chemotherapy, opportunties for intervention, supportive care measures, and challenges to the pharmuceutical industry in oncologic drug development.
This is a preview of subscription content, log in to check access.
Buy single article
Instant unlimited access to the full article PDF.
Price includes VAT for USA
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
This is the net price. Taxes to be calculated in checkout.
About this article
Cite this article
Markman, M. Cancer Drug Development Problems and Opportunities. Ther Innov Regul Sci 32, 1–5 (1998). https://doi.org/10.1177/009286159803200101
- Oncologic drug development
- Pharmaceutical industry